Our devices provide efficacious and efficient disinfection of target surfaces and can be effectively employed in the fight against Health Care Acquired Infections (HCAI) to significantly reduce or eliminate microbial load's presence on non-invasive medical devices.
We intend to remain at the forefront of the fight against infections by marketing systems that are truly implementable everywhere there is a need to fight Health Care Acquired Infections and /or eliminate pathogenic bacteria.
The 99 Technologies' project started out in 1999 as a philanthropic initiative with the aim of funding broad research in the field of nosocomial infections' prevention.
The entrepreneurial initiative
The results have generated a cutting-edge technology which represents a very effective and efficient contribution to the fight against nosocomial infections and microbial load control practices in general.
The company is located in Lugano, Switzerland, and it is currently marketing internationally the disinfection system derived from the 99Ts technology.
The highly innovative nature of the technology and the solid business planning associated to the 99 Technologies' project has attracted a highly diversified pool of investors.
Among them the local government of the Swiss Canton of Ticino through Agire Invest of the Agire Foundation, the Sator Private Equity Fund, and Sagittario SpA.
Sagittario SpA is a financial company with prevailing investments in high tech companies operating worldwide.
Agire Invest SA is responsible for selecting and financing the creation and development of start-ups and innovative projects for the Swiss Canton of Ticino.